DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award

About this funding opportunity

Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Patient-Centered Outcomes and Survivorship Award (PCOSA) promotes evidence-based and patient-centered approaches to improve health and lung cancer related outcomes and enhance the patient experience in defined populations. Research must address at least one of the FY26 LCRP areas of emphasis in the Health Outcomes and Survivorship category.

Distinctive Features:

• This funding mechanism requires the research team to include an advocate who is a lung cancer patient/survivor or caregiver.

• This funding mechanism allows proposed projects to include translational or clinical research, including pilot clinical trials.

Topic areas: General and Cross-cutting R&D, Life Sciences and Health.

Funding amount

This grant provides Varies in funding.

Deadline

Applications are due Sep 02, 2026. Confirm the exact closing time on the official program page before applying.

Who can apply

This opportunity is open to the following applicant types:

• Open to all applicant types

Eligibility

The program did not publish a separate eligibility statement. See the official opportunity page for the full eligibility criteria.

Agency

DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award is administered by Defense Health Agency Contracting Activity - DHACA (AMRAA), listed via Grants.gov.